Skip to content
sellModerate cluster of 8

Stelios Papadopoulos sold $1.6M of EXEL

director at EXELIXIS, INC.. 36,508 shares at an average of $44.35, traded May 15, 2025, filed May 16, 2025.

Warning score
40
Value
$1.6M
36,508 shares
Holdings after
1,279,416
-3% from before
From 52-week low
+82%
low $25.39, close $46.26
From 52-week high
0%
high $46.26, as of May 15, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $1.6M at market
    +25
  • Share of holdings sold
    Sold 2.8% of holdings
    0
  • Cluster
    8 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

EXELOct 9, 2026 · close 59.86
Since filing May 16, 2025: +31.9%SPY +33.2% · excess -1.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000939767-25-000080, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 15, 2025MOption exercise
Common Stock
+20,634$19.77$408k1,300,050May 16, 2025
May 15, 2025SOpen-market sale
Common Stock
-20,634$44.35$915k1,279,416May 16, 2025
May 15, 2025MOption exercise
Common Stock
+15,874$20.50$325k1,295,290May 16, 2025
May 15, 2025SOpen-market sale
Common Stock
-15,874$44.35$704k1,279,416May 16, 2025
May 15, 2025MOption exercise
Option (right to buy)derivative
-20,634$0.00$00May 16, 2025
May 15, 2025MOption exercise
Option (right to buy)derivative
-15,874$0.00$00May 16, 2025

Related signals

Other insiders at EXELIXIS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
24Weak
EXELsell 410b5-1
EXELIXIS, INC.
Jack L Wyszomierski
director
$325k
7,535 shares
-2%
42Moderate
EXELsell 410b5-1
EXELIXIS, INC.
Sue Gail Eckhardt
director
$805k
18,838 shares
-47%
47Moderate
EXELsell 9
EXELIXIS, INC.
Tomas J. Heyman
director
$201k
4,544 shares
-12%
55Moderate
EXELsell 9
EXELIXIS, INC.
Patrick J. Haley
EVP, Commercial
$1.5M
34,387 shares
-8%
45Moderate
EXELsell 7
EXELIXIS, INC.
Amy C. Peterson
EVP Prod Dev & Med Aff & CMO
$3.3M
72,776 shares
-14%
30Weak
EXELsell 810b5-1
EXELIXIS, INC.
Patrick J. Haley
EVP, Commercial
$6.5M
136,383 shares
-27%
55Moderate
EXELsell 8
EXELIXIS, INC.
Jeffrey Hessekiel
EVP & General Counsel
$1.2M
25,000 shares
-3%
47Moderate
EXELsell 7
EXELIXIS, INC.
Christopher J. Senner
EVP and CFO
$4.6M
100,000 shares
-9%
44Moderate
EXELsell 7
EXELIXIS, INC.
George Poste
director
$949k
20,634 shares
-11%
17Weak
EXELsell 410b5-1
EXELIXIS, INC.
Dana Aftab
CSO/EVP Disc & Trans Research
$59k
1,508 shares
-0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Stelios Papadopoulos sold $1.6M of EXEL | InsiderTell